Find your next launch before your competitors do.

RxScout scouts global approvals, patents, pipelines and deals, and tells your business-development team what to launch, in-license or partner on next.

• Every approved molecule scored for the Pakistani market
• Patent and exclusivity windows, biosimilars and new approvals as they happen
• Pipeline Radar: Phase 2/3 assets from Asian and global developers open for licensing
• Cited AI due-diligence dossiers with partners, deals and risks